Actinogen to present progress on Phase 2 trials at the BIO Investor Forum, San Francisco and Clinical Trials on Alzheimer's Disease (CTAD) Conference, Boston
Actinogen Medical's CEO, Dr. Steven Gourlay, will be attending meetings and presenting at conferences to discuss progress with the company's ...